Team:Paris/August 11

From 2008.igem.org

(Difference between revisions)
(PCR)
(PCR)
Line 29: Line 29:
| GTTTCTTCGAATTCGCGGCCGCTTCTAGAGTTGTATGTGCGTGTAGTGACGAGTACAG
| GTTTCTTCGAATTCGCGGCCGCTTCTAGAGTTGTATGTGCGTGTAGTGACGAGTACAG
| 58
| 58
-
|
+
|Don't amplify the both OmpR binding site
|- style="background: #dddddd;"
|- style="background: #dddddd;"
| style="background: #D4E2EF;" | O111
| style="background: #D4E2EF;" | O111
Line 35: Line 35:
| GTTTCTTCGAATTCGCGGCCGCTTCTAGAGTCATTTTTGCTTGCTAGCGTACGGAAAA
| GTTTCTTCGAATTCGCGGCCGCTTCTAGAGTCATTTTTGCTTGCTAGCGTACGGAAAA
| 58
| 58
 +
|Amplify the both OmpR binding site
 +
|- style="background: #dddddd;"
 +
| style="background: #D4E2EF;" | O113
 +
| FlhDC(nu)-R
 +
| GTTTCTTCCTGCAGCGGCCGCTACTAGTACAGAATAACCAACTTTATTTTTATG
 +
| 54
 +
|Don't amplify the natural rbs of FlhD (only promoter)
 +
|- style="background: #dddddd;"
 +
| style="background: #D4E2EF;" | O124
 +
| Oligo-pfliL-Forward-TRO
 +
| TCGAATTCGCGGCCGCTTCTAGAGCAAGGGCGTGTAACAGGCAAC
 +
| 45
 +
|
 +
|- style="background: #dddddd;"
 +
| style="background: #D4E2EF;" | O125
 +
| Oligo-pfliL-Reverse-TRO
 +
| TCCTGCAGCGGCCGCTACTAGTAGTCATGTGTTGCGGTCTTCCTGTG
 +
| 47
 +
|
 +
|- style="background: #dddddd;"
 +
| style="background: #D4E2EF;" | O130
 +
| Gene-FlhC-F
 +
| GTTTCTTCGAATTCGCGGCCGCTTCTAGATGAGTGAAAAAAGCATTGTTCAGG
 +
| 53
 +
|
 +
|- style="background: #dddddd;"
 +
| style="background: #D4E2EF;" | O131
 +
| Gene-FlhC-R-TRO
 +
| GTTTCTTCCTGCAGCGGCCGCTACTAGTATTATTAAACAGCCTGTACTCTCTGTTCATCC
 +
| 60
 +
|
 +
|- style="background: #dddddd;"
 +
| style="background: #D4E2EF;" | O132
 +
| Gene-FlhD-F
 +
| GTTTCTTCGAATTCGCGGCCGCTTCTAGATGCATACCTCCGAGTTGCTGAAAC
 +
| 53
 +
|Don't amplify the natural rbs of FlhD
 +
|- style="background: #dddddd;"
 +
| style="background: #D4E2EF;" | O133
 +
| Gene-FlhD-R-TRO
 +
| GTTTCTTCCTGCAGCGGCCGCTACTAGTATTATTAGGCCCTTTTCTTGCGCAGCGCTTCT
 +
| 60
|
|
|}
|}

Revision as of 10:16, 12 August 2008

← Yesterday

↓ Calendar ↑

Tomorrow →

Contents

Transformation

Digestion

PCR

We performed PCR on to amplify the sequence in order to have enough amount of DNA to carry out the following of our experiments.


PCR amplification

Protocol

  • List of Oligos :
Number Name Sequence Length Comments
O110 FlhDC-Uri-F GTTTCTTCGAATTCGCGGCCGCTTCTAGAGTTGTATGTGCGTGTAGTGACGAGTACAG 58 Don't amplify the both OmpR binding site
O111 FlhDC-Total-F GTTTCTTCGAATTCGCGGCCGCTTCTAGAGTCATTTTTGCTTGCTAGCGTACGGAAAA 58 Amplify the both OmpR binding site
O113 FlhDC(nu)-R GTTTCTTCCTGCAGCGGCCGCTACTAGTACAGAATAACCAACTTTATTTTTATG 54 Don't amplify the natural rbs of FlhD (only promoter)
O124 Oligo-pfliL-Forward-TRO TCGAATTCGCGGCCGCTTCTAGAGCAAGGGCGTGTAACAGGCAAC 45
O125 Oligo-pfliL-Reverse-TRO TCCTGCAGCGGCCGCTACTAGTAGTCATGTGTTGCGGTCTTCCTGTG 47
O130 Gene-FlhC-F GTTTCTTCGAATTCGCGGCCGCTTCTAGATGAGTGAAAAAAGCATTGTTCAGG 53
O131 Gene-FlhC-R-TRO GTTTCTTCCTGCAGCGGCCGCTACTAGTATTATTAAACAGCCTGTACTCTCTGTTCATCC 60
O132 Gene-FlhD-F GTTTCTTCGAATTCGCGGCCGCTTCTAGATGCATACCTCCGAGTTGCTGAAAC 53 Don't amplify the natural rbs of FlhD
O133 Gene-FlhD-R-TRO GTTTCTTCCTGCAGCGGCCGCTACTAGTATTATTAGGCCCTTTTCTTGCGCAGCGCTTCT 60

Culture of ligation transformants

  • 4 clones of each transformation were cultured in 7,5 mL LB + ampicilline. The colonies picked up were the rest of those already picked up from the transformation plate (for the PCR screening of August 8).
  • 37°C overnight
Ligation L128 L129 L130
Name pFlgA pFlgB pFlhB
Clone N° 1 2 3 4 1 2 6 7 1 2 7 8
Red fluorescence yes yes no no yes yes no no yes no no no